REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,824,217 | -15.3% | 596,854 | +2.9% | 0.00% | 0.0% |
| Q2 2023 | $11,593,780 | +10.1% | 579,979 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $10,527,405 | -22.2% | 556,711 | -6.7% | 0.00% | -33.3% |
| Q4 2022 | $13,527,894 | -18.9% | 596,468 | -5.5% | 0.00% | -25.0% |
| Q3 2022 | $16,682,000 | +35.0% | 631,163 | +26.2% | 0.00% | +33.3% |
| Q2 2022 | $12,353,000 | +212.5% | 500,125 | +320.0% | 0.00% | +200.0% |
| Q1 2022 | $3,953,000 | -62.2% | 119,078 | -62.7% | 0.00% | -50.0% |
| Q4 2021 | $10,449,000 | -33.8% | 319,547 | -15.1% | 0.00% | -33.3% |
| Q3 2021 | $15,776,000 | +6.0% | 376,342 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $14,887,000 | +20.9% | 383,204 | +6.2% | 0.00% | 0.0% |
| Q1 2021 | $12,311,000 | -62.8% | 360,927 | -50.5% | 0.00% | -66.7% |
| Q4 2020 | $33,099,000 | +125.5% | 729,691 | +36.8% | 0.01% | +125.0% |
| Q3 2020 | $14,677,000 | -33.7% | 533,316 | -11.2% | 0.00% | -42.9% |
| Q2 2020 | $22,125,000 | +7.1% | 600,754 | -5.8% | 0.01% | 0.0% |
| Q1 2020 | $20,652,000 | +14.7% | 637,805 | +45.1% | 0.01% | +40.0% |
| Q4 2019 | $18,004,000 | +64.4% | 439,429 | +42.8% | 0.01% | +66.7% |
| Q3 2019 | $10,952,000 | -33.0% | 307,634 | -3.4% | 0.00% | -40.0% |
| Q2 2019 | $16,354,000 | -12.8% | 318,349 | -2.8% | 0.01% | -16.7% |
| Q1 2019 | $18,762,000 | +31.7% | 327,377 | -3.6% | 0.01% | +20.0% |
| Q4 2018 | $14,249,000 | -55.2% | 339,655 | -19.4% | 0.01% | -37.5% |
| Q3 2018 | $31,827,000 | +2.3% | 421,548 | -2.8% | 0.01% | 0.0% |
| Q2 2018 | $31,125,000 | +290.5% | 433,801 | +62.5% | 0.01% | +700.0% |
| Q1 2018 | $7,970,000 | +58.0% | 267,030 | +76.0% | 0.00% | 0.0% |
| Q4 2017 | $5,044,000 | -6.7% | 151,722 | -7.5% | 0.00% | 0.0% |
| Q3 2017 | $5,404,000 | +140.2% | 164,023 | +44.0% | 0.00% | 0.0% |
| Q2 2017 | $2,250,000 | +230.4% | 113,906 | +222.7% | 0.00% | – |
| Q1 2017 | $681,000 | +36.7% | 35,300 | +31.4% | 0.00% | – |
| Q4 2016 | $498,000 | +127.4% | 26,871 | +71.7% | 0.00% | – |
| Q3 2016 | $219,000 | -79.1% | 15,650 | -88.0% | 0.00% | – |
| Q2 2016 | $1,047,000 | – | 130,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |